Loading data for ADIL — first visit, this takes a few seconds.

Preisalarm

ADial Pharmaceuticals Com... (ADIL)

NasdaqCM: ADIL · Echtzeitkurs · USD

4.39

+0.08 (1.86%)

Zum Schluss: Aug 18, 2026, 3:59 PM

5.76

+0.09%

Nachbörslich: 5:37 PM

1.86% (1D)

Geld	4.57
Marktkapitalisierung	15.11 Mio
Umsatz (TTM)	n/a
Nettogewinn (TTM)	-57.8 Mio
Beta	n/a
EPS (ttm)	-17.71
KGV (TTM)	n/a
Forward-KGV	-0.77
KBV (TTM)	-0.39
KUV (TTM)	n/a
Earnings Date	n/a

Brief	3.08
Volumen	51,676
Ø Vol. (20D)	458,140
Eröffnung	4.35
Vortagesschluss	4.31
Tagesspanne	4.26 - 4.63
52-Wk Range	1.31 - 10.75
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über ADIL

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The...

[Mehr lesen]

Branche Biotechnology

Sektor Healthcare

IPO Datum Jul 27, 2018

Mitarbeiter 5

Börse NasdaqCM

Tickersymbol ADIL

Website https://www.adial.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von ADial Pharmaceuticals Common Stock 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -7.98 Mio, ein Rückgang von -39.56 %.

Finanzberichte

Gewinnüberraschung

ADial Pharmaceuticals Common Stock hat die Quartalszahlen am May 8, 2026 veröffentlicht:

Umsatz von $0 verfehlt die Erwartungen um $0, mit NaN% Wachstum im Jahresvergleich.

EPS von -1.48 übertrifft die Erwartungen um 0.77, mit 82.59% Wachstum im Jahresvergleich.

Nachrichten

vor 2 Monaten · MT Newswires

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street

vor 2 Monaten · Stocktwits

ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally

Adial on Thursday announced that it has bought privately held Azora Therapeutics.

vor 7 Monaten · Zacks

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

vor 10 Monaten · The Fly

CoreWeave initiated, Instacart downgraded: Wall Street's top analyst calls

vor 11 Monaten · Benzinga

Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Tuesday received the final meeting minutes from its End of Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) held in July. The minute...

Seite 1 von 2